A Multi-center, Randomized, Double-blind, Placebo-controlled Study to Evaluate the Effects of Tracleer (Bosentan) on Oxygen Saturation and Cardiac Hemodynamics in Patients With Pulmonary Arterial Hypertension Related to Eisenmenger Physiology
Latest Information Update: 04 Nov 2021
At a glance
- Drugs Bosentan (Primary)
- Indications Pulmonary arterial hypertension
- Focus Therapeutic Use
- Sponsors Actelion Pharmaceuticals
Most Recent Events
- 05 Aug 2019 New trial record